Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
HK Stock MarketDetailed Quotes
CHINA HEALTH (00673)
- 0.570
- +0.050+9.62%
Market Closed Apr 30 10:25 CST
790.67MMarket Cap-12.95P/E (TTM)
0.630High0.570Low138.00KVolume0.580Open0.520Prev Close84.36KTurnover0.01%Turnover RatioLossP/E (Static)1.39BShares0.86052wk High-43.85P/B790.67MFloat Cap0.18552wk Low--Dividend TTM1.39BShs Float22769.254Historical High--Dividend LFY11.54%Range %0.125Historical Low0.611Avg Price6000Lot Size--Div Yield TTM--Div Yield LFY
CHINA HEALTH (00673) Income Statement
All
YOY
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4.98%19.61M | -35.02%38.94M | -33.92%18.68M | -21.57%59.93M | -12.55%28.27M | -28.60%76.41M | -23.08%32.32M | 21.77%107.03M | 25.76%42.02M | 94.62%87.89M |
| Operating income | 4.98%19.61M | -35.02%38.94M | -33.92%18.68M | -21.57%59.93M | -12.55%28.27M | -28.60%76.41M | -23.08%32.32M | 21.77%107.03M | 25.76%42.02M | 94.62%87.89M |
| Cost of sales | -6.45%-17.76M | 35.82%-29.71M | 28.18%-16.69M | 5.95%-46.29M | -0.80%-23.23M | 37.17%-49.22M | 28.65%-23.05M | -26.56%-78.34M | -33.87%-32.3M | -121.79%-61.9M |
| Operating expenses | -6.45%-17.76M | 35.82%-29.71M | 28.18%-16.69M | 5.95%-46.29M | -0.80%-23.23M | 37.17%-49.22M | 28.65%-23.05M | -26.56%-78.34M | -33.87%-32.3M | -121.79%-61.9M |
| Gross profit | -7.33%1.85M | -32.28%9.24M | -60.42%1.99M | -49.85%13.64M | -45.71%5.04M | -5.22%27.19M | -4.56%9.28M | 10.38%28.69M | 4.67%9.72M | 50.66%25.99M |
| Selling expenses | 40.31%-1.88M | 65.45%-6.14M | 62.74%-3.14M | -51.53%-17.77M | -107.84%-8.43M | -5.45%-11.73M | -5.05%-4.06M | -16.95%-11.12M | -53.09%-3.86M | ---9.51M |
| Administrative expenses | 13.72%-10.9M | -85.50%-62.7M | 12.78%-12.64M | -19.57%-33.8M | ---14.49M | 0.45%-28.27M | ---- | -2.25%-28.4M | ---- | 16.16%-27.77M |
| Impairment and provision | ---- | 4.30%-17.64M | ---- | ---18.44M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | 4.30%-17.64M | ---- | ---18.44M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---293K | ---- | ---- |
| Special items of operating profit | 119.13%715K | -29.74%10.11M | -256.56%-3.74M | 170.61%14.4M | 2,643.68%2.39M | -945.67%-20.39M | 161.70%87K | -61.42%2.41M | -104.19%-141K | 136.62%6.25M |
| Operating profit | 41.69%-10.22M | -59.95%-67.13M | -13.07%-17.52M | -26.44%-41.97M | -392.07%-15.5M | -281.10%-33.19M | -7.17%5.31M | -72.90%-8.71M | 339.26%5.72M | 85.27%-5.04M |
| Financing cost | -700.00%-672K | 22.94%-252K | 32.26%-84K | 85.09%-327K | 84.50%-124K | ---2.19M | -390.80%-800K | ---- | -8.67%-163K | -98.65%-294K |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---4M | ---1K | ---- | ---- | ---- |
| Special items of earning before tax | ---- | ---- | ---- | ---- | 97.30%-864K | ---- | -212.06%-32M | ---- | ---10.26M | ---- |
| Earning before tax | 38.16%-10.89M | -59.31%-67.38M | -6.81%-17.61M | -7.39%-42.29M | 40.05%-16.49M | -352.21%-39.38M | -484.79%-27.5M | -63.37%-8.71M | -85.19%-4.7M | 84.48%-5.33M |
| Tax | 394.12%50K | -118.23%-443K | 69.64%-17K | -14.69%-203K | -124.00%-56K | 56.30%-177K | 69.51%-25K | 67.02%-405K | 81.28%-82K | 14.43%-1.23M |
| After-tax profit from continuing operations | 38.50%-10.84M | -59.59%-67.82M | -6.55%-17.62M | -7.42%-42.5M | 39.90%-16.54M | -334.06%-39.56M | -475.29%-27.52M | -38.95%-9.11M | -60.70%-4.78M | 81.67%-6.56M |
| Earning after tax | 38.50%-10.84M | -59.59%-67.82M | -6.55%-17.62M | -7.42%-42.5M | 39.90%-16.54M | -334.06%-39.56M | -475.29%-27.52M | -38.95%-9.11M | -60.70%-4.78M | 81.67%-6.56M |
| Minority profit | -100.84%-476K | 98.66%-31K | 84.00%-237K | -192.92%-2.31M | -1,764.04%-1.48M | -19.57%2.49M | -78.96%89K | 160.84%3.09M | -58.61%423K | 31.08%1.19M |
| Profit attributable to shareholders | 40.40%-10.36M | -68.69%-67.79M | -15.45%-17.39M | 4.42%-40.19M | 45.46%-15.06M | -244.50%-42.05M | -430.27%-27.61M | -57.61%-12.21M | -30.21%-5.21M | 78.89%-7.74M |
| Basic earnings per share | 41.23%-0.0211 | -64.62%-0.1391 | -12.54%-0.0359 | 14.30%-0.0845 | 51.74%-0.0319 | -233.11%-0.0986 | -424.60%-0.0661 | -1,457.89%-0.0296 | -1,160.00%-0.0126 | 78.65%-0.0019 |
| Diluted earnings per share | 41.23%-0.0211 | -64.62%-0.1391 | -12.54%-0.0359 | 14.30%-0.0845 | 51.74%-0.0319 | -233.11%-0.0986 | -424.60%-0.0661 | -1,457.89%-0.0296 | -1,160.00%-0.0126 | 78.65%-0.0019 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"